Can we develop small molecular drug by abolishing PD1/PD-L1 binding?

PD1 immune checkpoint has been proven to be a successful anti-cancer drug target and FDA has approved a number of antibody drugs targetting PD1 or PD-L1 which have shown surprisingly good...

05 May 2019 3,764 4 View